Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133413) titled 'Efficacy Evaluation and Patient Selection for High-Risk Unresectable Hepatocellular Carcinoma Treated with TACE Combined with Targeted and Immunotherapy: A Multicenter Real-World Retrospective Study' on Sept. 26.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Air Force Medical University
Condition:
hepatocellular carcinoma
Intervention:
experimental group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-10-10
Target Sample Size: experimental group:705;control group:4616;
Countries of Recru...